亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

In Vitro Diagnostic Tests for Predicting New Cardiovascular Events

技术应用: Using an algorithm, the markedly improved risk prediction can be determined. Also, the invention describes a novel high-throughput assay to measure Lp-PLA2 on isolated Lp(a) particles or isolated apoB particles. Currently, the technique to detect Lp-PLA2 is done in plasma. This invention proposes to have a plate assay to capture Lp-PLA2 using specific antibodies to measure the particles. It is the use of the assay to detect Lp-PLA2 that is unique; the assay has been developed but has not yet been clinically evaluated.

详细技术说明: This invention demonstrates that by measuring the OxPL/apo-B levels and Lp-PLA2 mass (or activity) one obtains complementary and synergistic information with a significant increase in the "hazard ratio" for predicting new cardiovascular events. In addition, if you measure the lipoprotein (a) and the Lp-PLA2 mass, and analyze the data together you get similar information. Therefore, by doing these combined measurements simultaneously, you can determine a higher risk if new cardiovascular events. When a patient presents to a physician, the physician would order both an OxPL/apo-B level (and or Lp(a) ) and an Lp-PLA2 mass.

*Principal Investigation: Name: Sotirios Tsimikas
Department:

Name: Joseph Witztum
Department:

附加资料: Patent Number: US7939287B2
Application Number: US2009465930A
Inventor: Tsimikas, Sotirios | Witztum, Joseph
Priority Date: 14 May 2008
Priority Number: US7939287B2
Application Date: 14 May 2009
Publication Date: 10 May 2011
IPC Current: C12Q000160
US Class: 435011 | 43500611 | 514824 | 435006
Assignee Applicant: The Regents of the University of California
Title: Methods of identifying a subject having or at risk of having or developing coronary artery disease
Usefulness: Methods of identifying a subject having or at risk of having or developing coronary artery disease
Summary: The methods and kits are useful for determining a subject's predisposition to coronary artery disease, and for identifying a subject having or at risk of having or developing a cardiovascular disease and/or a cardiovascular event (all claimed).
Novelty: Determining a subject's predisposition to coronary artery disease comprises determining the subject's plasma oxidized phospholipids level and lipoprotein-associated phospholipase A2 mass or activity

欲了解更多信息，请点击这里